SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001178913-22-003079
Filing Date
2022-08-12
Accepted
2022-08-12 16:05:40
Documents
1
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 zk2228331.html 3  
1 zk2228331.xml 3 5803
  Complete submission text file 0001178913-22-003079.txt   7297
Mailing Address 18 EAST 16TH STREET NEW YORK NY 10003
Business Address 18 EAST 16TH STREET NEW YORK NY 10003 646-233-1454
Artemis Therapeutics, Inc. (Issuer) CIK: 0001062128 (see all company filings)

IRS No.: 841417774 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2890 Miscellaneous Chemical Products

Mailing Address
Business Address
CITRON SHIMON (Reporting) CIK: 0001284150 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-24431 | Film No.: 221160020